Home Biosimilar Antibodies Immunology & Inflammation TNF-alpha antibody Golimumab (Anti-TNFSF2 / TNFa) For research use only.
Not for use in humans.

Golimumab (Anti-TNFSF2 / TNFa)

Synonyms: CNTO-148

Golimumab (Anti-TNFSF2 / TNFa) is a human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. MW: 146.94 KD.

Golimumab (Anti-TNFSF2 / TNFa)

Purity & Quality Control

≥99

Choose Selective TNF-alpha Inhibitors

Biological Activity

Description Golimumab (Anti-TNFSF2 / TNFa) is a human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. MW: 146.94 KD.

Product Details

CAS No. 476181-74-5
Molecular Weight 146.94
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Golimumab (Anti-TNFSF2 / TNFa) | Golimumab (Anti-TNFSF2 / TNFa) supplier | purchase Golimumab (Anti-TNFSF2 / TNFa) | Golimumab (Anti-TNFSF2 / TNFa) cost | Golimumab (Anti-TNFSF2 / TNFa) manufacturer | order Golimumab (Anti-TNFSF2 / TNFa) | Golimumab (Anti-TNFSF2 / TNFa) distributor